HIGH-GRADE SEROUS OVARIAN CANCER PATIENT-DERIVED ORGANOIDS APPLICABLE FOR IN VIVO MODELS OF EMERGENCE OF RESISTANCE TO ANTI-VEGF TREATMENT

被引：0
|
作者：
Hladchenko, Liliia [1 ]
Kessler, Mirjana [1 ]
Trillsch, Fabian [1 ]
Burges, Alexandar [1 ]
Czogalla, Bastian [1 ]
Kraus, Fabian [1 ]
Mahner, Sven [1 ]
Chelariu-Raicu, Anca [1 ]
机构：
[1] LMU Univ Hosp, CCC Munich, Dept Obstet & Gynecol, Munich, Germany
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P03
引用
收藏
页码：3377 / 3378
页数：2
相关论文
共 50 条
  • [21] Application of high-grade serous ovarian cancer organoids in functional precision medicine
    Senkowski, Wojciech
    Gall-Mas, Laura
    Falco, Matias M.
    Li, Yilin
    Lavikka, Kari
    Crispino, Aura
    Oikkonen, Jaana
    Bulanova, Daria
    Chen, Yan-Jun
    Doncel, Elena M.
    Vossgrone, Karolin
    Erkan, Erdogan P.
    Dai, Jun
    Lundgren, Anastasia
    Huvila, Jutta
    Huhtinen, Kaisa
    Hynninen, Johanna
    Hautaniemi, Sampsa
    Vaharautio, Anna
    Wennerberg, Krister
    CANCER RESEARCH, 2024, 84 (06)
  • [22] Cowpea mosaic virus nanoparticles for the treatment of high grade serous ovarian cancer: A patient-derived xenograft study
    Dominick, C.
    Joseph, P.
    Ponting, E.
    Armstrong, A. J.
    Nakayama, J.
    Nagel, C. I.
    Zanotti, K.
    Waggoner, S. E.
    Steinmetz, N. F.
    DiFeo, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 93 - 94
  • [23] Design of effective combination therapies for high-grade serous ovarian cancer using patient -derived xenograft models
    Iavarone, Claudia
    Zervantonakis, Ioannis
    Chen, Hsing-Yu
    Palakurthi, Sangeetha S.
    Liu, Joyce F.
    Matulonis, Ursula
    Drapkin, Ronny
    Mills, Gordon
    Leverson, Joel
    Sampath, Deepak
    Brugge, Joan
    CANCER RESEARCH, 2016, 76
  • [24] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [25] Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
    Freimund, Alison E.
    Beach, Jessica A.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2018, 32 (06) : 983 - +
  • [26] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [27] Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer
    Farkkila, Anniina
    Nagaraj, Ashwini S.
    Pietila, Elina A.
    Salko, Matilda
    Erkan, Erdogan P.
    Niemiec, Iga
    Sirsikar, Aditi
    Bao, Jie
    Marchi, Giovanni
    Nowlan, Kirsten
    Hautaniemi, Sampsa
    Vaharautio, Anna
    Tang, Jing
    Haltia, Ulla-Maija
    Kekalainen, Eliisa
    Virtanen, Anni
    Salo, Tuula
    CANCER RESEARCH, 2024, 84 (05)
  • [28] A platform utilizing high-grade serous ovarian cancer organoids for prospective patient stratification in functional precision medicine
    Senkowski, Wojciech
    Gall-Mas, Laura
    Falco, Matias M.
    Li, Yilin
    Lavikka, Kari
    Kriegbaum, Mette C.
    Oikkonen, Jaana
    Bulanova, Daria
    Pietras, Elin J.
    Vossgrone, Karolin
    Chen, Yan-Jun
    Erkan, Erdogan P.
    Hog, Mia K.
    Larsen, Ida M.
    Lamminen, Tarja
    Kaipio, Katja
    Huvila, Jutta
    Virtanen, Anni
    Engelholm, Lars H.
    Christiansen, Pernille
    Rugiu, Eric Santoni
    Huhtinen, Kaisa
    Carpen, Olli
    Hynninen, Johanna
    Hautaniemi, Sampsa
    Vaharautio, Anna
    Wennerberg, Krister
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Transcriptional expression patterns of patient-derived tumorspheres predict outcomes in high-grade serous ovarian carcinoma.
    Boone, Jonathan David
    Johnston, Bobbi E.
    Cooper, Sara J.
    Straughn, John Michael
    Buchsbaum, Donald J.
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
    Nanki, Yoshiko
    Chiyoda, Tatsuyuki
    Hirasawa, Akira
    Ookubo, Aki
    Itoh, Manabu
    Ueno, Masaru
    Akahane, Tomoko
    Kameyama, Kaori
    Yamagami, Wataru
    Kataoka, Fumio
    Aoki, Daisuke
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345